Osteopore Past Earnings Performance

Past criteria checks 0/6

Osteopore's earnings have been declining at an average annual rate of -26.4%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 19.3% per year.

Key information

-26.4%

Earnings growth rate

130.9%

EPS growth rate

Medical Equipment Industry Growth5.8%
Revenue growth rate19.3%
Return on equity-1,126.2%
Net Margin-219.7%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

We Think Osteopore (ASX:OSX) Needs To Drive Business Growth Carefully

Aug 24
We Think Osteopore (ASX:OSX) Needs To Drive Business Growth Carefully

How Many Osteopore Limited (ASX:OSX) Shares Have Insiders Sold, In The Last Year?

Dec 29
How Many Osteopore Limited (ASX:OSX) Shares Have Insiders Sold, In The Last Year?

Revenue & Expenses Breakdown
Beta

How Osteopore makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ASX:OSX Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 232-552
30 Sep 232-552
30 Jun 232-570
31 Mar 232-560
31 Dec 222-441
30 Sep 222-441
30 Jun 221-441
31 Mar 221-450
31 Dec 211-450
30 Sep 211-340
30 Jun 211-340
31 Mar 211-240
31 Dec 202-240
30 Sep 201-230
30 Jun 201-230
31 Mar 201-230
31 Dec 190-230
31 Dec 181-120
31 Dec 171010
31 Dec 160-110

Quality Earnings: OSX is currently unprofitable.

Growing Profit Margin: OSX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: OSX is unprofitable, and losses have increased over the past 5 years at a rate of 26.4% per year.

Accelerating Growth: Unable to compare OSX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OSX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: OSX has a negative Return on Equity (-1126.2%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.